{"symbol": "DRNA", "companyName": "Dicerna Pharmaceuticals Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.dicerna.com", "description": "Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.", "CEO": "Douglas M. Fambrough", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}